Prospective evaluation of patients hospitalized with venous thromboembolism: Comparison between cancer and non-cancer patients

Israel Medical Association Journal

Volumn 8, Issue 12, 2006, Pages 848-852

  Kolomansky, Albert ^a,b   Hoffman, Ron ^a   Sarig, Galit ^a   Brenner, Benjamin ^a   Haim, Nissim ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Activated protein C resistance; Cancer; Global C; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; D DIMER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; COLON CANCER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; FEMALE; HOSPITAL PATIENT; HUMAN; IMMOBILIZATION; ISRAEL; LABORATORY TEST; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PREVALENCE; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURGERY; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTORS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HOSPITALIZATION; HUMANS; ISRAEL; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECEPTORS, CELL SURFACE; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33845878804     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O' Fallon WM, Melton LJ III. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999;159:445-53.
2. Silverstein MD, Heir JA, Mohr DN, Petterson TM, O' Fallon WM, Melton LJ III. Trends in incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-93.
3. Oger E. Incidence of venous thromboembolism: a community based study in Western France. Thromb Haemost 2000;83:657-60.
4. Trousseau A. Phlegmasia alba doleus. Lectures on clinical medicine, delivered at the Diew Paris. London: New Sydenham Society, 1872:281-95.
5. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med 1991;151:933-8.
6. Igbinovia A, Malik GM, Grillo IA, et al. Deep vein thrombosis in Assir region of Saudi Arabia: case-controi study. Angiology 1995;46:1107-13.
7. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep vein thrombosis in Asian-Americans. Am J Cardiol 2000;85:1334-7.
8. Stein PD, Patel KC, Kalra NK, et al. Deep vein thrombosis in a general hospital. Chest 2002;122:960-2.
9. Stein PD, Ilenry JW. Prevalence of acute pulmonary embolism among patients and at autopsy. Chest 1995;108:978-81.
10. Stein PD, Iluang II, Afzal A, Noor HA. Incidence of acute pulmonary embolism in a general hospital: relation to age, sex and race. Chest 1999;116:909-13.
11. Stein PD, Patel KC, Kalra NK, et al, Estimated incidence of acute pulmonary embolism in a community/teaching hospital. Chest 2002;121:802-5.
12. Meyer G, Emmerich J, Helly D, et al. Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med 2001:110:12-15.
13. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-62.
14. Piccioli A, Prandoni P, Goldhaber SZ. Epidemiologic characteristics, management and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's hospital DVT registry. Am Heart J 1996;132:1010-14.
15. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer ID, Anderson FA. The epidemiology of diagnosed pulmonary embolism and deep vein thrombosis in the elderly. Arch Intern Med 1994;154:861-6.
16. Goldhaber GZ, Visani L, de Rosa M, for ICOPER. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry. Lancet 1999;353(9162):1386-9.
17. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-73.
18. Rodengheiro F, Tosseto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1998;130:643-50.
19. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003;349:1227-35.
20. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002;87:575-9.
21. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005;6:401-10.
22. Bottasso B, Mari D, Coppola R, Santoro N, Vaglini M, Mannucci PM. Hypercoagulability and hyperfibrinolysis in patients with melanoma. Thromb Res 1996;81(3):345-52.
23. Haim N, Lanir N, Hoffman R, Haim A, Tsalik M, Brenner B. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. Am J Med 2001;110:91-6.
24. Sarig G, Michaeli Y, Lanir N, Brenner B, Haim N. Mechanisms for acquired protein C resistance in cancer patients. J Thromb Haemost 2005;3(3):589-90.
25. Goldenberg N, Kahn SR, Solymoss S. Markers of anticoagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol 2003;21:4194-9.